伊克力西斯公布2025年ESMO大会Cabometyx®(Cabozantinib)在晚期肺部和胸腺神经内分泌肿瘤的关键性3期临床试验亚组分析结果

美股速递
Oct 18, 2025

伊克力西斯公布2025年ESMO大会Cabometyx®(Cabozantinib)在晚期肺部和胸腺神经内分泌肿瘤的关键性3期临床试验亚组分析结果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10